医药导报2024，Vol.43Issue(3)：390-393,4.DOI:10.3870/j.issn.1004-0781.2024.03.010
中成药适应证点评难点与对策
Difficulties and Countermeasures of Prescription Indication Reviews of Chinese Patent Medicines
魏文浩 1莫愁 2何颖1
作者信息
- 1. 天津中医药大学第二附属医院药学部,天津 300250
- 2. 天津生物工程职业技术学院中药系,天津 300462
- 折叠
摘要
Abstract
Prescription indication reviews are the problematic points in reviewing prescriptions of Chinese patent medi-cines.However,there is no commonly recognized review standard.This article conducted a statistical analysis of the prescriptions reviewed by pharmacists from July to December 2022 in the Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine.Combined with work experience,we analyzed the results and reasons for unqualified indication reviews,combed out the difficulties of the indications review in Chinese patent medicines,and proposed feasible strategies to provide support for the stand-ardization and standardized development in reviewing prescriptions of Chinese patent medicines.关键词
中成药/适应证/处方点评/难点与对策Key words
Chinese patent medicine/Indications/Prescription reviews/Difficulties and countermeasures分类
医药卫生引用本文复制引用
魏文浩,莫愁,何颖..中成药适应证点评难点与对策[J].医药导报,2024,43(3):390-393,4.
